Deepak Soneji, MD, PhD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Clinical Trial of Remibrutinib vs. Teriflunomide in Relapsing forms of Multiple Sclerosis
    Date added:
    08/09/2023
    Date updated:
    08/09/2023
    Relationship end date:
    12/31/2025
Return to 0251_ABSMC_Interprofessional Journal Club-Identification and Management of Subclinical Multiple Sclerosis_Live